You are here

Prices & Quotes - UK Markets - Omega Diagnostics Group (ODX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 22.75p
Change Today:
-2.75p
Market Cap:
41.56m
Sector:
Health Care Equipment & Services

Omega still waiting on government for Covid-19 test manufacture details

By Josh White

Date: Monday 07 Jun 2021

LONDON (ShareCast) - (Sharecast News) - Medical diagnostics company Omega updated the market on its UK government manufacturing contract on Monday, reporting that it remained in regular dialogue with the Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen tests.
The AIM-traded firm said the capacity would use the "key pieces" of manufacturing equipment loaned by the UK government for that purpose.

It explained that it was still waiting for confirmation on which test it would be required to manufacture, adding that it was not in control of the process, which was taking longer than originally expected.

The company said it would provide a further update once a test was confirmed.

It said the ability to supply tests that were produced within the UK remained a "key priority" for the DHSC, and to that end the DHSC had facilitated initial commercial discussions between Omega and potential partner companies with lateral flow antigen tests to potentially provide UK manufacturing services.

In the meantime, Omega was currently supporting the government with additional cassetting and pouching services for other Covid-19 antigen lateral flow tests that are being deployed in the UK.

The company also confirmed that, as part of the UK government manufacturing contract announced on 11 February, it had received cash pre-production payments totalling 2.5m excluding VAT, with 2.0m of that cash payment received after the year-end on 31 March.

It said it expected that an amount per test, sufficient to recover the pre-production payment, would be deducted until such time as the funds had been repaid.

"Whilst confirmation from the DHSC of which test to produce has taken longer than we had expected, we are confident that we have the capacity to produce significant volumes of tests once we receive the requisite confirmation from DHSC," said chief executive officer Colin King.

"Obviously as soon as this is confirmed we will update shareholders."

At 1546 BST, shares in Omega Diagnostics were down 3.33% at 60.9p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ODX Market Data

Currency UK Pounds
Price 22.75p
Change Today -2.75p
52 Week High 99.50p
52 Week Low 22.55p
Volume 6,460,632
Shares Issued 182.68m
Market Cap 41.56m
Beta 1.60

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Price Trend
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector

ODX Dividends

No dividends found

Trades for 30-Nov-2021

Time Volume / Share Price
17:08 125,700 @ 22.75p
16:29 6,930 @ 22.95p
16:29 21,715 @ 22.97p
16:27 11,058 @ 22.78p
16:25 43,499 @ 22.98p

ODX Key Personnel

CEO Colin King
Chair Simon Gordon Douglas
CFO Christopher Paul Lea